Mengmeng Wang

915 total citations
41 papers, 575 citations indexed

About

Mengmeng Wang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Mengmeng Wang has authored 41 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Mengmeng Wang's work include Cancer-related molecular mechanisms research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and RNA modifications and cancer (8 papers). Mengmeng Wang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and RNA modifications and cancer (8 papers). Mengmeng Wang collaborates with scholars based in China, United States and India. Mengmeng Wang's co-authors include Denise M. O’Hara, Lindsay B. Avery, Alison Joyce, Hendrik Neubert, Yao‐Yun Fan, Sheldon S. Leung, Xin Xu, Nicole Piche‐Nicholas, Amy King and Lioudmila Tchistiakova and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Mengmeng Wang

40 papers receiving 560 citations

Peers

Mengmeng Wang
Fenjie Li China
Ling Y. Lee Australia
Cheng‐Pang Hsu United States
Troii Hall United States
Stephanie Holst Netherlands
Wilson Phung United States
Ding Wu China
Fenjie Li China
Mengmeng Wang
Citations per year, relative to Mengmeng Wang Mengmeng Wang (= 1×) peers Fenjie Li

Countries citing papers authored by Mengmeng Wang

Since Specialization
Citations

This map shows the geographic impact of Mengmeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Wang more than expected).

Fields of papers citing papers by Mengmeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengmeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Wang. The network helps show where Mengmeng Wang may publish in the future.

Co-authorship network of co-authors of Mengmeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengmeng Wang. A scholar is included among the top collaborators of Mengmeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengmeng Wang. Mengmeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Hongyu, Qi Gao, Mengmeng Wang, et al.. (2025). The novel piperine derivative MHJ-LN inhibits breast cancer by inducing apoptosis via p53 activation. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(7). 9031–9042. 2 indexed citations
2.
Wang, Mengmeng, et al.. (2024). Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response. Journal of Cancer Research and Clinical Oncology. 150(4). 171–171. 2 indexed citations
3.
Wang, Mengmeng, et al.. (2024). Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 113–129. 9 indexed citations
5.
Yang, Bin, Sheng Lian, Mengmeng Wang, et al.. (2023). Nocardia seriolae mediates granulomatous chronic inflammation of spleen in Micropterus salmoides through necroptosis. Aquaculture. 580. 740360–740360. 10 indexed citations
6.
Qin, Xiaowei, et al.. (2023). The effect of thalidomide on the invasive ability of gastric cancer cells by regulating miR-524-5p/FSTL1. Cellular and Molecular Biology. 69(14). 137–142. 1 indexed citations
7.
Wang, Mengmeng, Shuiping Liu, Lei Ge, et al.. (2022). Lipopolysaccharide aggravates canine influenza a (H3N2) virus infection and lung damage via mTOR/autophagy in vivo and in vitro. Food and Chemical Toxicology. 172. 113597–113597. 3 indexed citations
8.
Zhu, Jun, et al.. (2022). A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma. Annals of Translational Medicine. 10(8). 479–479. 6 indexed citations
9.
Chen, Di, Mengmeng Wang, Yushuang Xu, et al.. (2021). A Novel Autophagy-Related lncRNA Prognostic Signature Associated with Immune Microenvironment and Survival Outcomes of Gastric Cancer Patients. International Journal of General Medicine. Volume 14. 6935–6950. 8 indexed citations
10.
Tang, Jianming, et al.. (2020). CASC9 plays a role in salivary adenoid cystic carcinoma in vitro by upregulation of ACLY. Oral Diseases. 28(2). 352–363. 7 indexed citations
12.
He, Xiaoxiao, Liangliang Shi, Meng-jun Qiu, et al.. (2018). Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families. Biochemical and Biophysical Research Communications. 504(4). 878–884. 13 indexed citations
13.
Wang, Mengmeng, Yutian Zhan, Jianqing Chen, et al.. (2016). Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy. PubMed. 2016. 1–11. 1 indexed citations
14.
Hong, Tao, Mengmeng Wang, Man Zhang, et al.. (2016). MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 β Cells. PLoS ONE. 11(2). e0149954–e0149954. 28 indexed citations
15.
Wang, Mengmeng, Tetsuya Ishino, Alison Joyce, et al.. (2015). Faster in vivo clearance of human embryonic kidney than Chinese hamster ovary cell derived protein: Role of glycan mediated clearance. Journal of Bioscience and Bioengineering. 119(6). 657–660. 3 indexed citations
16.
Tumey, L. Nathan, Diane H. Boschelli, Jaechul Shim, et al.. (2014). Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4. Bioorganic & Medicinal Chemistry Letters. 24(9). 2066–2072. 34 indexed citations
17.
Chen, Jianqing, et al.. (2014). Comparison of Succinimidyl [125I]Iodobenzoate with Iodogen Iodination Methods to Study Pharmacokinetics and ADME of Biotherapeutics. Pharmaceutical Research. 31(10). 2810–2821. 15 indexed citations
18.
Joyce, Alison, et al.. (2014). One Mouse, One Pharmacokinetic Profile: Quantitative Whole Blood Serial Sampling for Biotherapeutics. Pharmaceutical Research. 31(7). 1823–1833. 42 indexed citations
19.
Ishino, Tetsuya, Mengmeng Wang, Lidia Mosyak, et al.. (2013). Engineering a Monomeric Fc Domain Modality by N-Glycosylation for the Half-life Extension of Biotherapeutics. Journal of Biological Chemistry. 288(23). 16529–16537. 28 indexed citations
20.
Wang, Mengmeng, Qi Wang, Hong Cai, et al.. (2010). Prediction of In Vivo Enantiomeric Compositions by Modeling In Vitro Metabolic Profiles. Journal of Pharmaceutical Sciences. 99(7). 3234–3245. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026